Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.71B | $1.88B | $1.65B | $1.54B | $1.69B | $1.64B | $1.53B | $1.58B |
| Gross profit | $1.71B | $1.88B | $1.65B | $1.54B | $1.69B | $1.64B | $1.53B | $1.58B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | $83.30M | $0 | $0 | — | $70.90M | $0 | $0 | — |
| Selling, general and administrative | $262.60M | $327.80M | $364.20M | $345.70M | $259.00M | $300.90M | $320.40M | $316.40M |
| Operating expenses | $599.10M | $570.40M | $629.10M | $565.00M | $562.70M | $534.30M | $578.20M | $560.20M |
| Operating income | $1.11B | $1.31B | $1.02B | $972.60M | $1.13B | $1.11B | $947.10M | $1.02B |
| Operating margin | 64.9% | 69.7% | 61.8% | 63.3% | 66.7% | 67.5% | 62.1% | 64.6% |
| EBITDA | $1.19B | $1.39B | $1.10B | $1.06B | $1.21B | $1.19B | $1.03B | $1.11B |
| Interest income | $1.43B | $1.39B | $1.78B | $1.55B | $1.52B | $892.70M | $936.50M | $1.03B |
| Interest expense | −$43.60M | −$43.60M | −$43.70M | −$44.00M | −$44.00M | −$41.70M | −$40.70M | −$40.20M |
| Income before taxes | $1.33B | $1.51B | $1.58B | $1.18B | $1.33B | $1.24B | $1.10B | $1.18B |
| Income taxes | $285.90M | $356.60M | $395.50M | $269.00M | $305.20M | $288.60M | $222.00M | $264.10M |
| Net income | $1.04B | $1.15B | $1.18B | $908.00M | $1.03B | $956.20M | $874.60M | $912.80M |
| Net margin | 61.1% | 61.4% | 71.7% | 59.1% | 60.6% | 58.2% | 57.3% | 57.6% |
| EPS, basic | $2.89 | $3.25 | $3.25 | $2.49 | $2.81 | $2.63 | $2.40 | $2.51 |
| EPS, diluted | $2.88 | $3.18 | $3.24 | $2.49 | $2.81 | $2.62 | $2.40 | $2.50 |
| Diluted shares | 361.28M | 363.21M | 360.24M | 360.42M | 360.36M | 360.23M | 360.09M | 359.99M |
Figures describe CME shares, not any token. As of Jul 24, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.